Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implantation | 3 | 2023 | 22 | 2.100 |
Why?
|
| Cochlear Implants | 3 | 2023 | 28 | 2.080 |
Why?
|
| Neuroma, Acoustic | 6 | 2022 | 10 | 2.050 |
Why?
|
| Tinnitus | 6 | 2019 | 12 | 1.950 |
Why?
|
| Vestibule, Labyrinth | 3 | 2022 | 6 | 1.730 |
Why?
|
| Otosclerosis | 8 | 2021 | 8 | 1.450 |
Why?
|
| Ear, Middle | 4 | 2019 | 8 | 1.430 |
Why?
|
| Stapes Surgery | 8 | 2021 | 8 | 1.320 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2023 | 14 | 1.060 |
Why?
|
| Postoperative Complications | 9 | 2021 | 916 | 1.010 |
Why?
|
| Internship and Residency | 2 | 2018 | 211 | 0.930 |
Why?
|
| Ear Neoplasms | 2 | 2015 | 7 | 0.930 |
Why?
|
| Hydroxyapatites | 3 | 2020 | 9 | 0.890 |
Why?
|
| Neurilemmoma | 2 | 2022 | 15 | 0.880 |
Why?
|
| Otolaryngology | 3 | 2020 | 29 | 0.860 |
Why?
|
| Humans | 48 | 2023 | 27074 | 0.830 |
Why?
|
| Speech Perception | 1 | 2023 | 49 | 0.820 |
Why?
|
| Otologic Surgical Procedures | 4 | 2017 | 4 | 0.810 |
Why?
|
| Retrospective Studies | 23 | 2023 | 3538 | 0.730 |
Why?
|
| Craniotomy | 2 | 2019 | 22 | 0.710 |
Why?
|
| Bone Cements | 2 | 2020 | 88 | 0.700 |
Why?
|
| Endoscopy | 2 | 2018 | 179 | 0.670 |
Why?
|
| Benign Paroxysmal Positional Vertigo | 1 | 2019 | 1 | 0.650 |
Why?
|
| Dizziness | 1 | 2019 | 18 | 0.640 |
Why?
|
| Temporal Bone | 2 | 2017 | 8 | 0.620 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2022 | 21 | 0.600 |
Why?
|
| Ear, Inner | 3 | 2019 | 3 | 0.580 |
Why?
|
| Malleus | 1 | 2017 | 1 | 0.580 |
Why?
|
| Treatment Outcome | 16 | 2023 | 3485 | 0.560 |
Why?
|
| Skull | 1 | 2017 | 21 | 0.550 |
Why?
|
| Stapedius | 1 | 2017 | 1 | 0.550 |
Why?
|
| Incidental Findings | 1 | 2017 | 13 | 0.540 |
Why?
|
| Vascular Malformations | 1 | 2017 | 5 | 0.540 |
Why?
|
| Ear Canal | 2 | 2022 | 4 | 0.530 |
Why?
|
| Cartilage | 1 | 2017 | 107 | 0.530 |
Why?
|
| Male | 26 | 2021 | 14772 | 0.530 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 255 | 0.520 |
Why?
|
| Middle Aged | 22 | 2021 | 8923 | 0.510 |
Why?
|
| Stroke | 1 | 2019 | 261 | 0.500 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 90 | 0.500 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 52 | 0.490 |
Why?
|
| Vestibular Diseases | 1 | 2015 | 4 | 0.490 |
Why?
|
| Microsurgery | 2 | 2015 | 42 | 0.490 |
Why?
|
| Exostoses | 1 | 2015 | 1 | 0.480 |
Why?
|
| Osteoma | 1 | 2015 | 5 | 0.480 |
Why?
|
| Adult | 21 | 2021 | 7831 | 0.480 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2019 | 683 | 0.480 |
Why?
|
| Microscopy | 1 | 2015 | 10 | 0.470 |
Why?
|
| Lighting | 1 | 2015 | 13 | 0.470 |
Why?
|
| Meniere Disease | 3 | 2021 | 3 | 0.460 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 2014 | 1 | 0.460 |
Why?
|
| Eyeglasses | 1 | 2014 | 3 | 0.460 |
Why?
|
| Eye Movements | 1 | 2014 | 11 | 0.460 |
Why?
|
| Physician's Role | 1 | 2014 | 17 | 0.440 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 130 | 0.420 |
Why?
|
| Adenoma | 1 | 2014 | 60 | 0.420 |
Why?
|
| Biomarkers | 1 | 2016 | 562 | 0.410 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2012 | 1 | 0.410 |
Why?
|
| Female | 25 | 2021 | 15213 | 0.410 |
Why?
|
| Eustachian Tube | 2 | 2019 | 4 | 0.410 |
Why?
|
| Acoustic Impedance Tests | 1 | 2011 | 1 | 0.370 |
Why?
|
| Hearing Loss | 2 | 2021 | 13 | 0.360 |
Why?
|
| Reoperation | 6 | 2021 | 925 | 0.360 |
Why?
|
| Aged | 17 | 2020 | 8997 | 0.360 |
Why?
|
| Hearing Loss, Sudden | 1 | 2010 | 1 | 0.360 |
Why?
|
| Heroin | 1 | 2010 | 2 | 0.360 |
Why?
|
| Hearing Aids | 1 | 2010 | 3 | 0.350 |
Why?
|
| Family Practice | 1 | 2010 | 15 | 0.340 |
Why?
|
| Triage | 1 | 2010 | 18 | 0.340 |
Why?
|
| Cerebellopontine Angle | 2 | 2020 | 4 | 0.340 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 348 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 261 | 0.300 |
Why?
|
| Stapes | 3 | 2021 | 3 | 0.270 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 4777 | 0.270 |
Why?
|
| Hearing | 3 | 2021 | 20 | 0.260 |
Why?
|
| Multicenter Studies as Topic | 2 | 2023 | 43 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 1112 | 0.250 |
Why?
|
| Encephalocele | 2 | 2022 | 22 | 0.250 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2022 | 2 | 0.250 |
Why?
|
| Adolescent | 7 | 2021 | 2172 | 0.240 |
Why?
|
| Tympanic Membrane | 2 | 2017 | 4 | 0.240 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2015 | 2 | 0.240 |
Why?
|
| Tympanic Membrane Perforation | 2 | 2021 | 3 | 0.230 |
Why?
|
| Endolymphatic Sac | 1 | 2004 | 3 | 0.230 |
Why?
|
| Databases as Topic | 1 | 2023 | 14 | 0.220 |
Why?
|
| Facial Nerve | 3 | 2020 | 13 | 0.200 |
Why?
|
| Cranial Fossa, Middle | 1 | 2022 | 4 | 0.200 |
Why?
|
| Radiosurgery | 2 | 2020 | 34 | 0.200 |
Why?
|
| Cochlea | 1 | 2022 | 2 | 0.200 |
Why?
|
| Mastoidectomy | 1 | 2022 | 1 | 0.200 |
Why?
|
| Ossicular Prosthesis | 2 | 2020 | 2 | 0.190 |
Why?
|
| Mastoid | 3 | 2022 | 3 | 0.190 |
Why?
|
| Ossicular Replacement | 1 | 2020 | 1 | 0.180 |
Why?
|
| Anesthesia, Local | 1 | 2020 | 7 | 0.180 |
Why?
|
| Anesthesia, General | 1 | 2020 | 25 | 0.180 |
Why?
|
| Facial Paralysis | 1 | 2020 | 11 | 0.180 |
Why?
|
| Patient Care Team | 2 | 2014 | 119 | 0.170 |
Why?
|
| Arteries | 1 | 2020 | 14 | 0.170 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2020 | 8 | 0.170 |
Why?
|
| Urban Health Services | 1 | 2020 | 14 | 0.170 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 122 | 0.170 |
Why?
|
| Young Adult | 5 | 2020 | 1994 | 0.160 |
Why?
|
| Ear Diseases | 1 | 2019 | 3 | 0.160 |
Why?
|
| Brain Abscess | 1 | 2019 | 5 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 3 | 2012 | 370 | 0.160 |
Why?
|
| Tuberculosis | 1 | 2019 | 19 | 0.160 |
Why?
|
| Disease Management | 1 | 2020 | 102 | 0.160 |
Why?
|
| Quality of Life | 1 | 2004 | 629 | 0.160 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 5 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 74 | 0.160 |
Why?
|
| Skull Base | 1 | 2019 | 34 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 86 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 90 | 0.150 |
Why?
|
| Telemedicine | 1 | 2020 | 97 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 111 | 0.150 |
Why?
|
| Sepsis | 1 | 2019 | 113 | 0.150 |
Why?
|
| Patient Selection | 1 | 2019 | 194 | 0.150 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 77 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2020 | 458 | 0.140 |
Why?
|
| Child | 4 | 2021 | 1295 | 0.140 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2021 | 12 | 0.140 |
Why?
|
| Risk Factors | 4 | 2021 | 2302 | 0.130 |
Why?
|
| Cadaver | 1 | 2017 | 375 | 0.130 |
Why?
|
| Chemokines | 1 | 2016 | 21 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 482 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2014 | 206 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 64 | 0.120 |
Why?
|
| Vestibular Function Tests | 1 | 2015 | 2 | 0.120 |
Why?
|
| Hearing Disorders | 1 | 2015 | 2 | 0.120 |
Why?
|
| Semicircular Canals | 1 | 2015 | 5 | 0.120 |
Why?
|
| Endometrium | 1 | 2015 | 8 | 0.120 |
Why?
|
| United States | 2 | 2018 | 2035 | 0.120 |
Why?
|
| Hemifacial Spasm | 1 | 2014 | 1 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2015 | 34 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 879 | 0.120 |
Why?
|
| Burns | 1 | 2015 | 19 | 0.120 |
Why?
|
| Nerve Compression Syndromes | 1 | 2014 | 20 | 0.120 |
Why?
|
| Melanoma | 1 | 2015 | 60 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 80 | 0.110 |
Why?
|
| HIV Infections | 1 | 2019 | 466 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 137 | 0.110 |
Why?
|
| Placebo Effect | 1 | 2014 | 12 | 0.110 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2013 | 1 | 0.110 |
Why?
|
| Vestibular Nerve | 1 | 2013 | 2 | 0.110 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2013 | 4 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 112 | 0.110 |
Why?
|
| Rotation | 1 | 2014 | 137 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2014 | 415 | 0.110 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 125 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2014 | 88 | 0.100 |
Why?
|
| Anxiety | 1 | 2014 | 156 | 0.100 |
Why?
|
| Gentamicins | 2 | 2002 | 17 | 0.100 |
Why?
|
| Hearing Loss, Conductive | 2 | 2021 | 3 | 0.100 |
Why?
|
| Comorbidity | 1 | 2014 | 481 | 0.100 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2014 | 108 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 300 | 0.090 |
Why?
|
| Bone Conduction | 2 | 2021 | 2 | 0.090 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 9 | 0.090 |
Why?
|
| Drug Overdose | 1 | 2010 | 4 | 0.090 |
Why?
|
| Auditory Threshold | 1 | 2010 | 21 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2011 | 114 | 0.090 |
Why?
|
| Auditory Perception | 1 | 2010 | 34 | 0.090 |
Why?
|
| Respiration | 1 | 2010 | 35 | 0.090 |
Why?
|
| Acoustic Stimulation | 1 | 2010 | 50 | 0.080 |
Why?
|
| Meditation | 1 | 2010 | 22 | 0.080 |
Why?
|
| Tympanoplasty | 2 | 2017 | 3 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 552 | 0.080 |
Why?
|
| Depression | 1 | 2014 | 444 | 0.080 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 100 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2010 | 235 | 0.070 |
Why?
|
| Time Factors | 2 | 2020 | 1433 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 1890 | 0.060 |
Why?
|
| Round Window, Ear | 1 | 2002 | 1 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2004 | 420 | 0.050 |
Why?
|
| Labyrinthine Fluids | 1 | 2002 | 1 | 0.050 |
Why?
|
| Otitis Media | 1 | 2002 | 5 | 0.050 |
Why?
|
| Incus | 1 | 2021 | 1 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 676 | 0.050 |
Why?
|
| Contraindications | 1 | 2021 | 31 | 0.050 |
Why?
|
| Granuloma | 1 | 2021 | 13 | 0.050 |
Why?
|
| Tertiary Healthcare | 1 | 2020 | 2 | 0.040 |
Why?
|
| Brain | 1 | 2010 | 1649 | 0.040 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 20 | 0.040 |
Why?
|
| Emergencies | 1 | 2020 | 32 | 0.040 |
Why?
|
| South Africa | 1 | 2019 | 13 | 0.040 |
Why?
|
| Myoclonus | 1 | 2019 | 9 | 0.040 |
Why?
|
| Neuroma | 1 | 2019 | 3 | 0.040 |
Why?
|
| Facial Neoplasms | 1 | 2019 | 4 | 0.040 |
Why?
|
| Meningioma | 1 | 2019 | 12 | 0.040 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 14 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 1144 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 68 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 82 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 237 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 54 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 474 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2017 | 138 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2017 | 129 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 347 | 0.030 |
Why?
|
| GATA2 Transcription Factor | 1 | 2015 | 1 | 0.030 |
Why?
|
| Transcription Factor AP-2 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2015 | 3 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 23 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 43 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 38 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 47 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 23 | 0.030 |
Why?
|
| Neuromuscular Agents | 1 | 2014 | 4 | 0.030 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2014 | 8 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 81 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 94 | 0.030 |
Why?
|
| Electromyography | 1 | 2014 | 71 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2015 | 137 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 273 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 336 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 25 | 0.010 |
Why?
|
| Fascia | 1 | 2002 | 8 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 641 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 1778 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 1792 | 0.010 |
Why?
|